United Therapeutics Corporation (UTHR)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for United Therapeutics Corporation is not provided in the data. DSO is a measure of how long it takes a company to collect its accounts receivable, indicating the efficiency of its accounts receivable management.
Without specific values for DSO over the given time periods, it is challenging to evaluate the company's collection efficiency and credit policies. DSO is typically calculated as (Accounts Receivable / Total Credit Sales) * Number of Days in the Period.
A lower DSO indicates that the company is able to collect its receivables more quickly, which is generally positive as it signifies effective credit control and efficient operations. On the other hand, a higher DSO may suggest issues with collections management or potential liquidity concerns if customers are delaying payments.
In order to provide a more thorough analysis and assessment of United Therapeutics Corporation's DSO trend and performance, specific numerical values for DSO across the given dates are needed for a more detailed interpretation.
Peer comparison
Dec 31, 2024